Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

My Most Challenging Neonatal Case: Epidermolysis Bullosa

Description

The presentation discusses a challenging neonatal case of Epidermolysis Bullosa (EB), a group of hereditary skin diseases characterized by fragile skin and blister formation. The speaker emphasizes the importance of comprehensive patient management that includes proper diagnosis, multidisciplinary treatment, family support, and future care strategies. Diagnostic processes involve distinguishing between acquired and hereditary causes, using genetic testing to identify specific protein deficiencies associated with EB. Treatment involves careful wound care to minimize injury, pain management, and nutritional support, especially for neonates with oral lesions. The need for collaboration among dermatologists, nurses, geneticists, and other specialists is highlighted to ensure holistic patient management. Furthermore, familial genetic counseling and psychological support for caregivers are crucial in managing the emotional and logistical challenges of caring for a child with EB. The speaker also notes recent advancements in treatment options, including topical therapies and gene therapies, emphasizing the need for ongoing research and patient monitoring. Overall, the aim is to deliver informed and compassionate care that improves patients’ quality of life and avoids complications associated with this rare condition.

View more

Conclusions

  • The presentation focused on the management and diagnosis of pediatric epidermolysis bullosa (EB), emphasizing the complexity of the condition for both patients and families.
  • It highlighted the importance of a multidisciplinary approach to care, integrating dermatologists, pediatricians, geneticists, and psychological support in managing EB.
  • Early diagnosis and genetic counseling are crucial for effective management of EB.
  • The use of personalized treatment strategies, including pain management and nutritional support, significantly enhances patient outcomes.
  • Recent therapies such as Oleogel-S10 and gene therapy with B-VEC have demonstrated promising results in reducing wound burden and improving quality of life for patients with EB.
  • Ongoing research into innovative therapies and a deeper understanding of EB pathology is critical for future treatment improvements and disease modification.
  • Family support and education are essential to empower caregivers and improve overall management strategies for affected children.
  • Bardham A et al, Nature, 2020
  • Has C et al. BJD, 2020.
  • Mariath LM et al, Ann Bras Dermatol, 2020.
  • Saad R et al, BJD, 2024.
  • Gurevich I et al, Nat Med, 2022.
  • Hou PC et al. Am J Clin Dermatol, 2021.
  • Bageta ML et al, J Derm Ven, 2021.